B
MEDP icon

Bailard’s Medpace MEDP Stock Holding History

Bailard’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$238K Hold
450
– – ﹤0.01% 705
2026
Q1 		$216K Hold
450
– – 0.01% 694
2025
Q4 		$253K Hold
450
– – 0.01% 649
2025
Q3 		$231K Buy
+450
New +$196K 0.01% 693
2024
Q4 		– Sell
-750
Closed -$250K – 794
2024
Q3 		$250K Hold
750
– – 0.01% 656
2024
Q2 		$309K Hold
750
– – 0.01% 538
2024
Q1 		$303K Hold
750
– – 0.01% 565
2023
Q4 		$230K Sell
750
-400
-35% -$108K 0.01% 636
2023
Q3 		$278K Hold
1,150
– – 0.01% 559
2023
Q2 		$276K Hold
1,150
– – 0.01% 536
2023
Q1 		$216K Buy
+1,150
New +$238K 0.01% 627
2019
Q1 		– Sell
-8,200
Closed -$434K – 572
2018
Q4 		$434K Sell
8,200
-3,500
-30% -$192K 0.03% 329
2018
Q3 		$701K Buy
+11,700
New +$640K 0.04% 264

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Bailard's MEDP Position: Q2 2026 in Review

Bailard held its Medpace (MEDP) position steady in Q2 2026 at 450 shares worth $238K. The position accounts for ﹤0.01% of the portfolio, ranked #705.

Bailard first reported a position in MEDP in Q3 2018 and has held it in 13 quarters since. The position peaked at $701K in Q3 2018. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Bailard held 450 shares of Medpace worth $238K as of Q2 2026.
  • Bailard left its Medpace share count unchanged in Q2 2026.
  • Medpace made up ﹤0.01% of Bailard's portfolio in Q2 2026, its #705 holding.
  • Bailard first reported a position in Medpace in Q3 2018 and has held it in 13 quarters since.
  • Bailard's Medpace position peaked at $701K in Q3 2018.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Bailard's 13F filing for Q2 2026, filed 30 Jul 2026.